Metropolitan Life Insurance Company (MetLife)’s Axcelis ACLS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,714	Closed	-$191K	–	33
2024 Q1	$191K	Sell	1,714 -136	-7%	-$16.2K	0.01%	735
2023 Q4	$240K	Sell	1,850 -64	-3%	-$8.82K	0.01%	660
2023 Q3	$312K	Buy	1,914 +121	+7%	+$21.3K	0.02%	543
2023 Q2	$329K	Buy	1,793 +30	+2%	+$4.32K	0.02%	529
2023 Q1	$235K	Sell	1,763 -267	-13%	-$31.4K	0.01%	616
2022 Q4	$161K	Hold	2,030	–	–	0.01%	808
2022 Q3	$123K	Hold	2,030	–	–	0.01%	900
2022 Q2	$111K	Hold	2,030	–	–	﹤0.01%	998
2022 Q1	$153K	Sell	2,030 -6,835	-77%	-$467K	0.01%	956
2021 Q4	$661K	Hold	8,865	–	–	0.01%	1240
2021 Q3	$417K	Sell	8,865 -1,519	-15%	-$66.1K	0.01%	1578
2021 Q2	$420K	Buy	10,384 +533	+5%	+$22.1K	0.01%	1627
2021 Q1	$405K	Sell	9,851 -512	-5%	-$19.1K	0.01%	1543
2020 Q4	$302K	Hold	10,363	–	–	﹤0.01%	1674
2020 Q3	$228K	Hold	10,363	–	–	﹤0.01%	1695
2020 Q2	$289K	Hold	10,363	–	–	0.01%	1577
2020 Q1	$190K	Hold	10,363	–	–	﹤0.01%	1618
2019 Q4	$250K	Hold	10,363	–	–	﹤0.01%	1765
2019 Q3	$177K	Hold	10,363	–	–	﹤0.01%	1953
2019 Q2	$156K	Hold	10,363	–	–	﹤0.01%	2053
2019 Q1	$209K	Hold	10,363	–	–	﹤0.01%	1878
2018 Q4	$184K	Hold	10,363	–	–	﹤0.01%	1879
2018 Q3	$204K	Hold	10,363	–	–	﹤0.01%	1997
2018 Q2	$205K	Buy	10,363 +8,121	+362%	+$179K	﹤0.01%	1931
2018 Q1	$55.2K	Sell	2,242 -8,121	-78%	-$213K	﹤0.01%	2433
2017 Q4	$297K	Sell	10,363 -10,230	-50%	-$322K	﹤0.01%	1627
2017 Q3	$563K	Hold	20,593	–	–	﹤0.01%	1608
2017 Q2	$431K	Hold	20,593	–	–	﹤0.01%	1806
2017 Q1	$387K	Hold	20,593	–	–	﹤0.01%	1834
2016 Q4	$300K	Buy	20,593 +2,060	+11%	+$28K	﹤0.01%	2094
2016 Q3	$246K	Sell	18,533 -2,409	-12%	-$28K	﹤0.01%	2212
2016 Q2	$225K	Hold	20,942	–	–	﹤0.01%	2239
2016 Q1	$235K	Buy	20,942 +116	+0.6%	+$1.19K	﹤0.01%	2078
2015 Q4	$216K	Buy	20,826 +133	+0.6%	+$1.41K	﹤0.01%	2219
2015 Q3	$221K	Buy	20,693 +9,583	+86%	+$117K	﹤0.01%	2221
2015 Q2	$132K	Sell	11,110 -12,697	-53%	-$147K	﹤0.01%	2569
2015 Q1	$227K	Sell	23,807 -18	-0.1%	-$186	﹤0.01%	2001
2014 Q4	$244K	Hold	23,825	–	–	﹤0.01%	2264
2014 Q3	$190K	Buy	23,825 +18,225	+325%	+$137K	﹤0.01%	2405
2014 Q2	$45K	Sell	5,600 -16,816	-75%	-$125K	﹤0.01%	2741
2014 Q1	$193K	Sell	22,416 -1,153	-5%	-$10.6K	﹤0.01%	2479
2013 Q4	$230K	Hold	23,569	–	–	﹤0.01%	2375
2013 Q3	$199K	Buy	23,569 +15,512	+193%	+$126K	﹤0.01%	2428
2013 Q2	$59K	Buy	+8,057	New	+$46.8K	﹤0.01%	2680

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACLS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 1,714 shares — an estimated $191K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACLS in Q2 2013 and held it in 44 quarters. The position peaked at $661K in Q4 2021. 391 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,714 Axcelis shares in Q2 2024, an estimated $191K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Axcelis in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Axcelis position peaked at $661K in Q4 2021.
391 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.